查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404777

微流体市场规模、份额、趋势分析报告：按应用、材料、技术、地区、细分市场预测，2024-2030

Microfluidics Market Size, Share & Trends Analysis Report By Application (Medical/Healthcare, Non-Medical), By Material (Silicon, Glass), By Technology, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

微流控市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球微流控市场规模将达719亿美元，2024年至2030年复合年增长率为12.22%。

晶载微流体等改进技术的引入预计将增加对基于微流体的设备的需求。分析和临床研究人员研究活动的增加也推动了对微流体设备的需求。例如，2022 年 5 月，明尼苏达大学的一组研究人员开发了一种用于疾病诊断的创新微流控晶片，该晶片使用最少的组件，并且可以透过智慧型手机无线操作。

基于小型微流体的工具在消费者中越来越受欢迎，这促使公司对其开发进行投资。由于微流控是晶片实验室设备的基本原理，因此它具有许多优点，例如最小的样品体积、最少的试剂用量、减少废弃物和快速处理。增强型全自动微流体和强大的模组化正在为该市场中的製造商创造成长机会。这是因为模组化晶片可以与多个设备连接。此外，在药物研发领域运作的公司正在努力最大限度地减少管理费用和时间表，以抵消由于专利到期的药物数量而导致的预期收益下降。

微流控在诊断领域的应用正在扩大，特别是在 POC 诊断中。微流控整合生物感测器技术也对此进行了补充，预计将增强 POC 诊断。微流控元件与POC设备的结合致力于实现灵敏度、稳定性、精确性、经济性，并获得微创POC技术。微流控 POC 技术有望透过确保个体化、早期发现疾病和轻鬆监测来增强患者护理。

此外，COVID-19 进一步扩大了微流体的使用范围。现场护理测试使用小型设备、受控流程和有限的检查週期。这使得单一或多个研究实验室服务能够同时评估生物样本并诊断有害疾病。总的来说，阶段评估和快速发现病毒爆发对于克服疫情并快速诊断至关重要。因此，将微流体装置与即时检测相结合可以提高检测效率。同时，使用微流控晶片进行现场检测增加了用户便利性，提高了灵敏度和准确性，并减少了检测时间。

此外，微流体产业的几项收购旨在增强技术，以扩大微流体相关应用的范围。 2021 年 6 月，丹纳赫公司宣布其生命科学业务收购了加拿大解决方案供应商 Precision Nanosystems (PNI)。 PNI 提供独特的遗传套件平台，包括透过基于微流体的平台进行 LNP 输送和奈米颗粒製造，进一步补充了该公司的生命科学产品系列。

另一方面，高昂的营运成本在一定程度上阻碍了微流控市场的成长。微流控晶片的製造面临挑战，例如需要黏合机械部件以形成最终密封结构的开放通道结构。开放通道是透过蚀刻玻璃或硅形成的。此步骤耗时、昂贵，并且需要使用腐蚀性化学物质。此外，大多数微流体原型製作方法与批量过程不相容，且复杂且昂贵。

微流体市场报告亮点

  • 从应用来看，医疗细分市场将在2023年占据市场最高收益占有率份额，2024-2030年复合年增长率为12.56%。
  • 从材料来看，聚二甲基硅氧烷（PDMS）领域预计将在2023年占据最高的市场占有率，2024年至2030年的复合年增长率为13.59%。
  • 从技术角度来看，晶载领域预计将在 2023 年占据市场主导地位，预测期内复合年增长率为 11.06%。
  • 预计到 2023 年，北美将主导市场，收益占有率为 42.69%，预测期内复合年增长率为 10.57%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
    • 市场机会分析
  • 产业分析工具
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第四章微流控市场：应用业务分析

  • 微流控市场：应用变化分析
  • 医疗保健
    • PCR和RT-PCR
    • 凝胶电泳
    • 微阵列
    • 酵素连结免疫吸附试验
    • 其他的
  • 非医疗用途

第五章微流体市场：材料业务分析

  • 微流控市场：材料变化分析
  • 硅
  • 玻璃
  • 聚合物
  • 聚二甲基硅氧烷 (PDMS)
  • 其他的

第六章微流体市场：技术业务分析

  • 微流控市场：技术变迁分析
  • 晶载实验室
    • 医疗保健
    • 非医疗的
  • 晶载的器官
    • 医疗保健
    • 非医疗的
  • 连续流微流体
    • 医疗保健
    • 非医疗的
  • 光流控和微流控
    • 医疗保健
    • 非医疗的
  • 声流体学和微流体学
    • 医疗保健
    • 非医疗的
  • 电泳和微流体
    • 医疗保健
    • 非医疗的

第七章 区域业务分析

  • 2023 年及 2030 年微流控市场占有率（按地区）
  • 北美洲
    • 北美微流控市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲微流控市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太微流控市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲微流控市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA微流控市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 公司分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd
    • PerkinElmer, Inc
    • Agilent Technologies, Inc
    • Bio-Rad Laboratories, Inc
    • Danaher Corporation
    • Abbott
    • Thermo Fisher Scientific Inc.
    • Standard BioTools, Inc.
Product Code: GVR-1-68038-056-9

Microfluidics Market Growth & Trends:

The global microfluidics market size is expected to reach USD 71.90 billion by 2030, registering CAGR of 12.22% from 2024 to 2030, according to a new report by Grand View Research, Inc. The demand for microfluidics-based devices is expected to increase due to the introduction of improved technology such as digital microfluidics, which enables on-chip biochemical analysis. An increase in research activities undertaken by analytical and clinical researchers have also driven the demand for microfluidics device. For instance, in May 2022, a research team from the University of Minnesota developed an innovative microfluidic chip for disease diagnosing that uses a minimum number of components and can be operated wirelessly by a smartphone.

Miniature microfluidic-based tools are gaining significant popularity among consumers, which has encouraged companies to invest in their development. Since microfluidics is the underlying principle of lab-on-a-chip devices, it offers various benefits such as minimal sample volume, minimal reagent usage, reduced waste, and rapid processing. Fully automated microfluidics with enhanced functional capabilities, and robust modularity are creating growth opportunities for manufacturers operating in the market. This can be attributed to the fact that modular chips can interface with several instruments. In addition, companies operating in the field of drug discovery are striving to minimize overhead costs and timelines to offset the estimated decline in revenue owing to a significant number of drugs going off-patent.

The implementation of microfluidics is expanding in the field of diagnostics, especially in POC diagnostics. This is also supplemented by microfluidics-integrated biosensor technologies that are expected to enhance POC diagnostics. The combination of microfluidic components with POC devices is largely focused on achieving sensitivity, stability, accuracy, affordability, and obtaining minimally invasive POC technology. Microfluidic POC technologies are expected to enhance patient care by ensuring personalization, early disease detection, and easy monitoring.

In addition, COVID-19 has further upscaled the use of microfluidics. Point-of-care testing involves small equipment, regulates the process, and has limited testing cycles. This allows single or multiple research laboratory services to evaluate biological samples and diagnose harmful diseases simultaneously. In general, stage assessment and rapid detection of viral epidemics are vital to overcoming pandemic situations and diagnosing rapidly. Therefore, combining microfluidic devices with point-of-care testing enhances detection efficiency. At the same time, point-of-care testing of microfluidic chips enhances user accessibility, improves sensitivity and accuracy, and reduces the detection time, all of which are advantageous in detecting SARS-CoV-2.

Further, several acquisitions in the microfluidics industry are aimed at enhancing technologies for expanding the scope of microfluidics-related applications. In June 2021, Danaher Corporation announced that Precision NanoSystems (PNI), a Canada-based solution provider, was acquired by its life science business. PNI offered proprietary genetic toolkit platforms, including LNP delivery and nanoparticle manufacturing via the microfluidic-based platform, which further complemented the company's portfolio of life science products.

On the other hand, high operational costs hinder the microfluidics market growth to a certain extent. The fabrication of microfluidics chips has certain issues such as open channel construction that require bonding of machine parts to form a final enclosed structure. The open channel is formed by the etching of glass or silicon. This step is slow, costly, and requires the use of aggressive chemicals. In addition, most of the microfluidic prototyping methods are not compatible with the batch process, and are also complicated and costly.

Microfluidics Market Report Highlights:

  • Based on application, the medical segment held the highest revenue share of the market in 2023 and is expected to exhibit a CAGR of 12.56% from 2024-2030.
  • Based on material, the polydimethylsiloxane (PDMS) segment held the highest market share in 2023 and is expected to grow at a CAGR of 13.59% from 2024-2030.
  • Based on technology, the lab-on-a-chip segment dominated the market in 2023 and is expected to reveal a CAGR of 11.06% during the forecast period.
  • North America dominated the market with a revenue share of 42.69% in 2023 and is projected to exhibit a CAGR of 10.57% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Application & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Application & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for low-volume sample analysis
      • 3.2.1.2. Growing penetration of microfluidics in diagnostics market
      • 3.2.1.3. Introduction of advanced technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High operational cost
      • 3.2.2.2. Interfacing and integration
      • 3.2.2.3. Complex fabrication process
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Investments by companies in technological advancements
      • 3.2.3.2. Growing adoption of point-of-care (POC) tests
      • 3.2.3.3. Expansion of application scope for microfluidics technology
  • 3.3. Industry Analysis Tools
    • 3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.3.2. Porter's Five Forces Analysis
  • 3.4. COVID-19 Impact Analysis

Chapter 4. Microfluidics Market: Application Business Analysis

  • 4.1. Microfluidics Market: Application Movement Analysis
  • 4.2. Medical
    • 4.2.1. PCR & RT-PCR
      • 4.2.1.1. Global PCR & RT-PCR Market, 2018 - 2030 (USD Million)
    • 4.2.2. Gel electrophoresis
      • 4.2.2.1. Global Gel electrophoresis Market, 2018 - 2030 (USD Million)
    • 4.2.3. Microarrays
      • 4.2.3.1. Global Microarrays Market, 2018 - 2030 (USD Million)
    • 4.2.4. ELISA
      • 4.2.4.1. Global ELISA Market, 2018 - 2030 (USD Million)
    • 4.2.5. Others
      • 4.2.5.1. Global Others Market, 2018 - 2030 (USD Million)
  • 4.3. Non-Medical
    • 4.3.1. Global Non-Medical Market, 2018 - 2030 (USD Million)

Chapter 5. Microfluidics Market: Material Business Analysis

  • 5.1. Microfluidics Market: Material Movement Analysis
  • 5.2. Silicon
    • 5.2.1. Global Silicon Market, 2018 - 2030 (USD Million)
  • 5.3. Glass
    • 5.3.1. Global Glass Market, 2018 - 2030 (USD Million)
  • 5.4. Polymer
    • 5.4.1. Global Polymer Market, 2018 - 2030 (USD Million)
  • 5.5. Polydimethylsiloxane (PDMS)
    • 5.5.1. Global Polydimethylsiloxane (PDMS) Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Microfluidics Market: Technology Business Analysis

  • 6.1. Microfluidics Market: Technology Movement Analysis
  • 6.2. Lab-on-a-chip
    • 6.2.1. Global Lab-on-a-chip Market, 2018 - 2030 (USD Million)
    • 6.2.2. Medical
      • 6.2.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.2.3. Non-medical
      • 6.2.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.3. Organs-on-chips
    • 6.3.1. Global Organs-on-chips Market, 2018 - 2030 (USD Million)
    • 6.3.2. Medical
      • 6.3.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.3.3. Non-medical
      • 6.3.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.4. Continuous flow microfluidics
    • 6.4.1. Global Continuous Flow Microfluidics Market, 2018 - 2030 (USD Million)
    • 6.4.2. Medical
      • 6.4.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.4.3. Non-medical
      • 6.4.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.5. Optofluidics and microfluidics
    • 6.5.1. Global Optofluidics and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.5.2. Medical
      • 6.5.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.5.3. Non-medical
      • 6.5.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.6. Acoustofluidics and microfluidics
    • 6.6.1. Global Acoustofluidics and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.6.2. Medical
      • 6.6.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.6.3. Non-medical
      • 6.6.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.7. Electrophoresis and microfluidics
    • 6.7.1. Global Electrophoresis and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.7.2. Medical
      • 6.7.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.7.3. Non-medical
      • 6.7.3.1. Non-medical Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Microfluidics Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target disease prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. U.S. Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target disease prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Canada Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target disease prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. UK Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target disease prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Germany Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target disease prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. France Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target disease prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Italy Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target disease prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Spain Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target disease prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Denmark Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target disease prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Sweden Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target disease prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Norway Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target disease prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Japan Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target disease prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. China Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target disease prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. India Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target disease prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Australia Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target disease prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Thailand Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target disease prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. South Korea Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target disease prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Brazil Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target disease prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Mexico Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target disease prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Argentina Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target disease prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. South Africa Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target disease prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Saudi Arabia Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target disease prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. UAE Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target disease prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Kuwait Microfluidics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Illumina, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PerkinElmer, Inc
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Agilent Technologies, Inc
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Danaher Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Abbott
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Thermo Fisher Scientific Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Standard BioTools, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 Some commercialized POCT devices based on NAT.
  • Table 2 List of FDA-approved microfluidic-based POC tests
  • Table 3 Research institutes in Canada working on microfabricated microfluidics
  • Table 4 Overview of magnetic, colorimetric, plasmonic, electrochemical, and lateral flow assays
  • Table 5 Several approaches for microfluidic PCR devices including commercial PCR devices
  • Table 6 Major types of micro mosaic immunoassays
  • Table 7 Particle-focusing techniques applied in microfluidic flow cytometry
  • Table 8 Comparison of detection of food allergens by commercial ELISA kits and the microfluidic ELISA biosensor
  • Table 9 Materials and their respective technologies for micro structuring
  • Table 10 Comparison of polymers with glass
  • Table 11 Distinctive features of continuous-flow microfluidics and their usage in materials synthesis
  • Table 12 Different applications of acoustofluidic separation
  • Table 13 List of established companies
  • Table 14 List of emerging companies (contd.)
  • Table 15 List of Secondary Sources
  • Table 16 List of Abbreviations
  • Table 17 Global Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Global Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 19 Global Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Global Microfluidics Market, by Region, 2018 - 2030 (USD Million)
  • Table 21 North America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 North America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 23 North America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 U.S. Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 U.S. Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 26 U.S. Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Canada Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Canada Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 29 Canada Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Europe Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Europe Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 33 Europe Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Germany Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Germany Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 36 Germany Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 UK Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 UK Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 39 UK Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Norway Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Norway Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 42 Norway Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 45 Sweden Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Denmark Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 48 Denmark Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 France Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 France Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 51 France Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Italy Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Italy Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 54 Italy Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 China Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 China Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 61 China Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Japan Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Japan Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 64 Japan Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 India Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 India Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 67 India Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Australia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Australia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 70 Australia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Thailand Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Thailand Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 73 Thailand Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 75 Latin America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Latin America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 77 Latin America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Brazil Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Brazil Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 80 Brazil Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Mexico Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Mexico Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 83 Mexico Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Argentina Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Argentina Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 86 Argentina Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 South Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 South Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 93 South Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 97 UAE Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 UAE Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 99 UAE Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 101 Kuwait Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 102 Kuwait Microfluidics Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microfluidics market estimation process
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Microfluidics market segmentation
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market driver impact
  • Fig. 15 Market restraint impact
  • Fig. 16 Emerging applications of automated and miniaturized microfluidics
  • Fig. 17 Companies developing automated and miniaturized microfluidics
  • Fig. 18 Extending applications of microfluidics technology
  • Fig. 19 Photolithographic procedure
  • Fig. 20 Types of COVID-19 tests
  • Fig. 21 Advantages of lab-on-chip devices for COVID-19 testing
  • Fig. 22 Microfluidics market: technology outlook and key takeaways
  • Fig. 23 Microfluidics market: technology movement analysis
  • Fig. 24 Microfluidics market estimates and forecast for medical technologies, 2018 - 2030 (USD Million)
  • Fig. 25 Microfluidics market estimates and forecast for PCR & RT-PCR, 2018 - 2030 (USD Million)
  • Fig. 26 Microfluidics market estimates and forecast for gel electrophoresis, 2018 - 2030 (USD Million)
  • Fig. 27 Microfluidics market estimates and forecast for microarrays, 2018 - 2030 (USD Million)
  • Fig. 28 Microfluidics market estimates and forecast for ELISA, 2018 - 2030 (USD Million)
  • Fig. 29 Different detection methods for microfluidic flow cytometry
  • Fig. 30 Microfluidics market estimates and forecast for other technologies, 2018 - 2030 (USD Million)
  • Fig. 31 Microfluidics market estimates and forecast for non-medical technologies, 2018 - 2030 (USD Million)
  • Fig. 32 Microfluidics market: material outlook and key takeaways
  • Fig. 33 Microfluidics market: material movement analysis
  • Fig. 34 Pros and cons of silicon
  • Fig. 35 Microfluidics market estimates and forecast for silicon, 2018 - 2030 (USD Million)
  • Fig. 36 Advantages of glass as microfluidic material
  • Fig. 37 Microfluidics market estimates and forecast for glass, 2018 - 2030 (USD Million)
  • Fig. 38 Types of polymers used to develop microfluidic devices
  • Fig. 39 Microfluidics market estimates and forecast for polymer, 2018 - 2030 (USD Million)
  • Fig. 40 Microfluidics market estimates and forecast for PDMS, 2018 - 2030 (USD Million)
  • Fig. 41 Microfluidics market estimates and forecast for other materials, 2018 - 2030 (USD Million)
  • Fig. 42 Microfluidics market: application outlook and key takeaways
  • Fig. 43 Microfluidics market: Application movement analysis
  • Fig. 44 Microfluidics market estimates and forecast for lab-on-a-chip, 2018 - 2030 (USD Million)
  • Fig. 45 Medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Non-medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Microfluidics market estimates and forecast for organs-on-chip, 2018 - 2030 (USD Million)
  • Fig. 48 Medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Non-medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Microfluidics market estimates and forecast for continuous flow microfluidics, 2018 - 2030 (USD Million)
  • Fig. 51 Medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Non-medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Microfluidics market estimates and forecast for optofluidics and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 54 Medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Non-medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Microfluidics market estimates and forecast for acoustofluidics and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 57 Medical applications of acoustofluidics
  • Fig. 58 Medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Non-medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Microfluidics market estimates and forecast for electrophoresis and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 61 Medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Non-medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Regional marketplace: regional outlook and key takeaways
  • Fig. 64 Microfluidics regional outlook, 2021 & 2030
  • Fig. 65 North America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 U.S. microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Canada microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Europe microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Germany microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 UK microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 France microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Italy microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73Denmark microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Norway microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Sweden microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Asia Pacific microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Japan microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 China microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 India microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Australia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Thailand microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Mexico microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 MEA microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Strategy framework
  • Fig. 92 Participant categorization